Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kota Kodama

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 4, 2026
[Current Status of Drug Lag in Rare Disease Treatment and a Multifaceted Approach to Resolving It]Kota Kodama
Drug Discovery Today|March 26, 2018
Strategic R&D transactions in personalized drug developmentTomohiro Makino, Yeongjoo Lim, Kota Kodama
Drug Discovery Today|November 5, 2022
The gap between development and manufacturing in gene therapy: Strategic options for overcoming trapsYu Nishida, Kota Kodama, Shintaro Sengoku
Foods (Basel, Switzerland)|May 14, 2025
The Co-Evolution of Markets and Regulation in the Japanese Functional Food Industry: Balancing Risk and BenefitKeigo Sato, Kota Kodama, Shintaro Sengoku
International Journal of Environmental Research and Public Health|July 8, 2020
Corporate Characteristics and Adoption of Good Manufacturing Practice for Dietary Supplements in JapanKeigo Sato, Kota Kodama, Shintaro Sengoku
Foods (Basel, Switzerland)|October 26, 2024
Driving Innovation Through Regulatory Design and Corporate Behaviour: A Case Study of Functional Food Industry in JapanKeigo Sato, Kota Kodama, Shintaro Sengoku
Drug Discovery Today|May 10, 2023
Strategic trends of pharmaceutical companies: A growth model through regional focus and inter-regional alliancesAkinori Nakashima, Kota Kodama, Shintaro Sengoku
Drug Discovery Today|October 12, 2022
What is the importance of difference in LCM strategy in drug development? - Learnings from Keytruda and OpdivoKota Kodama, Arisa Djurian, Yeongjoo Lim
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 4, 2026
[Programmed Medical Device (SaMD) and Orphan Drug Innovation Processes and Industrial Systems]Rei Goto, Shintaro Sengoku, Kota Kodama
JMIR Diabetes|October 21, 2021
The Significance of Alliance Networks in Research and Development of Digital Health Products for Diabetes: Observational StudySatoru Kikuchi, Kota Kodama, Shintaro Sengoku
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 4, 2026
[Current Status of Drug Lag in Rare Disease Treatment and a Multifaceted Approach to Resolving It]Kota Kodama
Drug Discovery Today|March 26, 2018
Strategic R&D transactions in personalized drug developmentTomohiro Makino, Yeongjoo Lim, Kota Kodama
Drug Discovery Today|November 5, 2022
The gap between development and manufacturing in gene therapy: Strategic options for overcoming trapsYu Nishida, Kota Kodama, Shintaro Sengoku
Foods (Basel, Switzerland)|May 14, 2025
The Co-Evolution of Markets and Regulation in the Japanese Functional Food Industry: Balancing Risk and BenefitKeigo Sato, Kota Kodama, Shintaro Sengoku
International Journal of Environmental Research and Public Health|July 8, 2020
Corporate Characteristics and Adoption of Good Manufacturing Practice for Dietary Supplements in JapanKeigo Sato, Kota Kodama, Shintaro Sengoku
Foods (Basel, Switzerland)|October 26, 2024
Driving Innovation Through Regulatory Design and Corporate Behaviour: A Case Study of Functional Food Industry in JapanKeigo Sato, Kota Kodama, Shintaro Sengoku
Drug Discovery Today|May 10, 2023
Strategic trends of pharmaceutical companies: A growth model through regional focus and inter-regional alliancesAkinori Nakashima, Kota Kodama, Shintaro Sengoku
Drug Discovery Today|October 12, 2022
What is the importance of difference in LCM strategy in drug development? - Learnings from Keytruda and OpdivoKota Kodama, Arisa Djurian, Yeongjoo Lim
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 4, 2026
[Programmed Medical Device (SaMD) and Orphan Drug Innovation Processes and Industrial Systems]Rei Goto, Shintaro Sengoku, Kota Kodama
JMIR Diabetes|October 21, 2021
The Significance of Alliance Networks in Research and Development of Digital Health Products for Diabetes: Observational StudySatoru Kikuchi, Kota Kodama, Shintaro Sengoku
Pageof 6